Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Total Liabilities (2021 - 2025)

Zymeworks' Total Liabilities history spans 3 years, with the latest figure at $132.0 million for Q3 2023.

  • For Q3 2023, Total Liabilities rose 9.56% year-over-year to $132.0 million; the TTM value through Sep 2023 reached $132.0 million, up 9.56%, while the annual FY2022 figure was $155.8 million, 11.23% up from the prior year.
  • Total Liabilities for Q3 2023 was $132.0 million at Zymeworks, down from $153.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $155.8 million in Q4 2022 and bottomed at -$282.4 million in Q1 2022.
  • The 3-year median for Total Liabilities is $129.6 million (2023), against an average of $40.5 million.
  • The largest YoY upside for Total Liabilities was 168.89% in 2023 against a maximum downside of 9.56% in 2023.
  • A 3-year view of Total Liabilities shows it stood at $140.0 million in 2021, then increased by 11.23% to $155.8 million in 2022, then dropped by 15.25% to $132.0 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Total Liabilities are $132.0 million (Q3 2023), $153.1 million (Q2 2023), and $127.2 million (Q1 2023).